Elena D’Aiuto

Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells

Teresa Troiani, Erika Martinelli, Stefania Napolitano et al. · Clinical Cancer Research · 2013 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines

Floriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte et al. · Clinical Cancer Research · 2013 · 117 citations

Medicine, Oncology, Pharmacology +14

Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion

Veronica Santarlasci, Laura Maggi, Manuela Capone et al. · Immunity · 2012 · 115 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lung and colorectal cancer cells

Erika Martinelli, Teresa Troiani, Elena D’Aiuto et al. · International Journal of Cancer · 2013 · 91 citations · Full text

Medicine, Oncology, Pharmacology +15

NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells

Elvira Crescenzi, Francesco Pacifico, Alfonso Lavorgna et al. · Oncogene · 2011 · 74 citations

Life Sciences, Immunology, Oncology +16